TipRanks
55% OFF
PC:STRAM

Stramsen Biotech Inc

6200 Savoy Dr Suite #1202 - 12th Floor Houston, Texas 77036, UShttps://www.stramsenbiotech.com/Therapeutics

Stramsen Biotech Inc is an emerging leader in the plant-based biopharmaceutical industry, focused on accelerating clinical development and growth. The company leverages innovative plant-based technologies to advance its biopharmaceutical initiatives, aiming to enhance its position in the market through strategic investments and recruitment of experienced management and scientific teams.

Leadership & Board

Current Number of Employees
6
Current LinkedIn Followers
413

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$50M
Total Funding Rounds
2
Latest Funding Amount
$25M
Latest Funding Round
Series B
Post-Money Valuation
―

Employee Trend

Stramsen Biotech Inc had 6 employees as of October 12, 2026. The number of employees increased by 3 (100.00%) week-over-week.

6Latest Employee Count
3(100.00%)Week-Over-Week Change
02468Jan 26, 2026Feb 10, 2026Feb 23, 2026Mar 09, 2026Mar 23, 2026Apr 06, 2026Apr 27, 2026May 11, 2026May 25, 2026Jun 08, 2026Jun 22, 2026Jul 06, 2026Jul 27, 2026Aug 10, 2026Aug 24, 2026Sep 07, 2026Sep 21, 2026Oct 05, 2026

Social Trend

Stramsen Biotech Inc had 413 followers as of October 12, 2026. The number of followers increased by 2 (0.49%) week-over-week.

413Latest Followers Count
2(0.49%)Week-Over-Week Change
0200400600800Jan 26, 2026Feb 10, 2026Feb 23, 2026Mar 09, 2026Mar 23, 2026Apr 06, 2026Apr 27, 2026May 11, 2026May 25, 2026Jun 08, 2026Jun 22, 2026Jul 06, 2026Jul 27, 2026Aug 10, 2026Aug 24, 2026Sep 07, 2026Sep 21, 2026Oct 05, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
May 07, 2025Series B$25.00M―
Apr 07, 2025Investment$25.00M―

Investors

Investor NameFunding Round
Global Emerging MarketsSeries B
GEM Global Yield LLC SCSInvestment

Similar Companies

A snapshot of private companies similar to Stramsen Biotech Inc, helping you discover and navigate related company profiles.

Related News and Analysis